Addiction

Qnovia, Inc. Announces Leadership Transition and Strategic Appointments to Support UK Commercialization Strategy

Mario Danek Appointed President and CEO; James Watson Joins as COO, Francesca Lanuza Appointed Director of Regulatory Affairs, and Dr.…

10 months ago

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

Vancouver, Canada, April 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

10 months ago

Hazelden Betty Ford Foundation and Netsmart Collaborate to Enhance Behavioral Healthcare with Meaningful AI and Integrated CareFabric® Platform

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#ArtificialIntelligence--The Hazelden Betty Ford Foundation, a leader in non-profit addiction and behavioral health treatment for 75 years,…

10 months ago

Amid Surgeon General’s Warning on Alcohol and Cancer, Middle-Aged Women Rethink Drinking

New Survey Reveals 30% of Middle-Aged Women are Embracing Sober Curiosity as 45% Express Dependency Concerns DENVER, April 3, 2025…

10 months ago

BetterLife Pharma Appoints Corporate Advisor

VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB…

10 months ago

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals…

10 months ago

ProvaDent Reviews (Is It Safe And Legit?) Investigative Report On Ingredients, Side Effects, And Benefits!

TALLMADGE, Ohio, March 28, 2025 (GLOBE NEWSWIRE) -- ProvaDent is precisely fabricated to support oral health by promoting a balanced…

10 months ago

Emerald Isle Health & Recovery Announces New Chief Executive Officer

SUN CITY, Ariz., March 25, 2025 (GLOBE NEWSWIRE) -- Emerald Isle Health & Recovery proudly announces the appointment of Danielle…

10 months ago

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Emergent BioSolutions will lead commercial launch efforts to increase access to intranasal naloxone and combat opioid overdose poisonings in CanadaLONDON…

11 months ago